.JM FITZ<.iERALI), PT MACKLF:M. Proceedings of a workshop on near fatal asthma. Can Respir .J 1995;2(2): l 13-126.Corll'LTn has been L'XpressL'd aboul rising asthma morbid ity and mortal ity, although till' latter appears to have decline d recently. A reasonable surrog ate for fatal as thma is an episode of near fatal asthma (NFA). The e tiology of episodes of NFA appears to be multifactorial. Features that w ou ld characteri1.e asthma patients at risk of NFA h ave been diffiL'lllt to defi ne but have included psychosocial barriers. environmental exposure s, inadequa te or inappropriate physiL·ian aml/or patient res ponses to deteriorati ng asth ma and , in particular, overreliance on symptomatic bronc hodil ato r therapy. The association between fatal asthma and NFA with hcta-agonist use has been controvers ial, with it being argued that high use of beta-agonists reflect s severity of as thma as opposed to being causal. Studies in the laboratory and ambulatory care setting suggest that regular compared with as-rc4uircd use of beta-agonists is a ssoci ate d with worsening in asthma control. Although a reduced pe rception of dyspnea has been identified in some a sthma patient s, it is not universal ly present in those with NFA. Retrospective data suggest that hyperinflation of the thora x, as judged by total lung capacity, may be a useful marker for subjects at risk of NFA . f<"uture studies should better characteri ze these ris1' factors and develop manage ment s trateg ies (both therapeutic and educational) that might reduce the risk of subjects experienc ing episodes of NFA and, by exte n sion, red uc ing the continm·J unacccptahk mortality associated with asthma .